Detailed answers about DR D G KIMOGLOU ADVANCED BIOMEDICAL RESEARCH LTD, including incorporation, status, business activity, and accounts information.
When was DR D G KIMOGLOU ADVANCED BIOMEDICAL RESEARCH LTD founded?
DR D G KIMOGLOU ADVANCED BIOMEDICAL RESEARCH LTD was officially incorporated on 28 July 2025 and is registered under company number 16609085. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is DR D G KIMOGLOU ADVANCED BIOMEDICAL RESEARCH LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of DR D G KIMOGLOU ADVANCED BIOMEDICAL RESEARCH LTD?
DR D G KIMOGLOU ADVANCED BIOMEDICAL RESEARCH LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does DR D G KIMOGLOU ADVANCED BIOMEDICAL RESEARCH LTD do?
DR D G KIMOGLOU ADVANCED BIOMEDICAL RESEARCH LTD operates in the following sector: 99999 - Dormant Company. This provides insight into the company's primary business activity and industry focus.
What is DR D G KIMOGLOU ADVANCED BIOMEDICAL RESEARCH LTD's registered address?
The registered office address of DR D G KIMOGLOU ADVANCED BIOMEDICAL RESEARCH LTD is 128 CITY ROAD, LONDON, UNITED KINGDOM, EC1V 2NX. This is the official address filed with Companies House for legal and statutory correspondence.
Is DR D G KIMOGLOU ADVANCED BIOMEDICAL RESEARCH LTD financially stable?
Financial accounts for DR D G KIMOGLOU ADVANCED BIOMEDICAL RESEARCH LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.